- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Therapy for Primary Sjögren’s Syndrome: Where are We Now?
Authors
Keywords
-
Journal
BIODRUGS
Volume 35, Issue 6, Pages 593-610
Publisher
Springer Science and Business Media LLC
Online
2021-11-05
DOI
10.1007/s40259-021-00505-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
- (2021) Elvira Favoino et al. AUTOIMMUNITY REVIEWS
- Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’
- (2021) Bin Wang et al. ANNALS OF THE RHEUMATIC DISEASES
- Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease
- (2021) Claire L. Langrish et al. JOURNAL OF IMMUNOLOGY
- JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study
- (2021) Tom Le Voyer et al. RHEUMATOLOGY
- JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials
- (2021) Stephanie Keeling et al. Expert Review of Clinical Immunology
- Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis
- (2021) Gwenny M. Verstappen et al. Nature Reviews Rheumatology
- Antibodies to both Ro52 and Ro60 may identify Sjögren's syndrome patients best suited for clinical trials of disease‐modifying therapies
- (2021) Berkan Armağan et al. ARTHRITIS CARE & RESEARCH
- Establishment of functional epithelial organoids from human lacrimal glands
- (2021) Sang Yun Jeong et al. Stem Cell Research & Therapy
- The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren’s Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution
- (2021) Krisztina Szabó et al. Frontiers in Immunology
- A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score
- (2021) Loukas Chatzis et al. JOURNAL OF AUTOIMMUNITY
- Toward better outcomes in Sjögren's syndrome: The promise of a stratified medicine approach
- (2020) Ghaith Noaiseh et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Increased activation of PI3 kinase-δ predisposes to B-cell lymphoma
- (2020) Anne Durandy et al. BLOOD
- Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren’s syndrome murine model
- (2020) Runzhong Fu et al. Scientific Reports
- Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren's syndrome reveals a pathogenic signature
- (2020) Gwenny M. Verstappen et al. JOURNAL OF AUTOIMMUNITY
- Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren’s syndrome
- (2020) Xiaoyan Wang et al. RHEUMATOLOGY
- Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies
- (2020) Wanlin Jin et al. Journal of Immunology Research
- Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial
- (2020) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells
- (2020) Keiko Aota et al. INFLAMMATION
- Current State of Knowledge on Primary Sjögren’s Syndrome, an Autoimmune Exocrinopathy
- (2020) Dorian Parisis et al. Journal of Clinical Medicine
- M3 muscarinic acetylcholine receptor–reactive Th17 cells in primary Sjögren’s syndrome
- (2020) Saori Abe et al. JCI Insight
- Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
- (2020) Fabio Basta et al. Rheumatology and Therapy
- Salivary gland epithelial cells from patients with Sjögren’s syndrome induce B-lymphocyte survival and activation
- (2020) Elodie Rivière et al. ANNALS OF THE RHEUMATIC DISEASES
- Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma
- (2020) Elena Pontarini et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome
- (2020) Maria Juarez et al. RHEUMATOLOGY
- Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
- (2020) Edurne Rujas et al. Nature Communications
- Nuclease Therapy Improves Severe Fatigue in Primary Sjögren’s Syndrome: A Randomized Clinical Trial
- (2020) James Posada et al. Arthritis & Rheumatology
- Systematic review of safety and efficacy of belimumab in treating immune‐mediated disorders
- (2020) Celine Kaegi et al. ALLERGY
- Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
- (2020) Renaud Felten et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study
- (2020) Alex Walker et al. EXPERIMENTAL DERMATOLOGY
- Bruton’s tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice
- (2020) Ahmed Nadeem et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study
- (2020) Yoshiya Tanaka et al. RHEUMATOLOGY
- Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects
- (2020) Bin Wang et al. JOURNAL OF AUTOIMMUNITY
- Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies
- (2019) Andres Forero-Torres et al. BLOOD
- Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
- (2019) Thomas Dörner et al. ANNALS OF THE RHEUMATIC DISEASES
- Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren’s syndrome
- (2019) Grazyna Wieczorek et al. ANNALS OF THE RHEUMATIC DISEASES
- B cell checkpoints in autoimmune rheumatic diseases
- (2019) Samuel J. S. Rubin et al. Nature Reviews Rheumatology
- A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity
- (2019) Jodi L. Karnell et al. Science Translational Medicine
- A Meta‐Analysis of Treatment for Primary Sjögren's Syndrome
- (2019) Lucy L Chu et al. ARTHRITIS CARE & RESEARCH
- The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials
- (2019) Renaud Felten et al. AUTOIMMUNITY REVIEWS
- Interleukin‐17 and Interleukin‐22 synergy linking inflammation and EMT ‐ dependent fibrosis in Sjögren's syndrome
- (2019) Margherita Sisto et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren’s Syndrome
- (2019) Amandine Charras et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records
- (2019) Pulukool Sandhya et al. International Journal of Rheumatic Diseases
- Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification
- (2019) Efstathia K. Kapsogeorgou et al. JOURNAL OF AUTOIMMUNITY
- Unique Sjögren’s syndrome patient subsets defined by molecular features
- (2019) Judith A James et al. RHEUMATOLOGY
- EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
- (2019) Manuel Ramos-Casals et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren’s syndrome via follicular helper T cells
- (2019) Jin-Sil Park et al. CYTOKINE
- Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production
- (2019) Anthony Lau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody
- (2018) Jacinda Ristov et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome
- (2018) Miao Miao et al. ANNALS OF THE RHEUMATIC DISEASES
- Signalling pathways identified in salivary glands from primary Sjögren’s syndrome patients reveal enhanced adipose tissue development
- (2018) Lara A. Aqrawi et al. AUTOIMMUNITY
- The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity
- (2018) Jasper Rip et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: Systematic review and meta-analysis
- (2018) Hind Letaief et al. JOINT BONE SPINE
- Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations
- (2018) Aigli G. Vakrakou et al. JOURNAL OF AUTOIMMUNITY
- Primary Sjögren’s Syndrome
- (2018) Xavier Mariette et al. NEW ENGLAND JOURNAL OF MEDICINE
- Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21−/low B Cells From Patients With Sjögren's Syndrome
- (2018) Salomé Glauzy et al. Arthritis & Rheumatology
- Salivary Gland Stem Cells Age Prematurely in Primary Sjögren's syndrome
- (2018) Sarah Pringle et al. Arthritis & Rheumatology
- Janus kinase 1 inhibition suppresses interferon-induced B cell activating factor production in human salivary gland: potential therapeutic strategy for primary Sjögren's syndrome
- (2018) Jaeseon Lee et al. Arthritis & Rheumatology
- The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome
- (2018) Valter R. Fonseca et al. Arthritis & Rheumatology
- Editorial: Epratuzumab: Reveille or Requiem? Teachable Moments for Lupus and Sjögren's Syndrome Clinical Trials
- (2018) Daniel J. Wallace Arthritis & Rheumatology
- Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome
- (2018) Jacques-Eric Gottenberg et al. Arthritis & Rheumatology
- Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis
- (2018) Laurence E. Cheng et al. Arthritis & Rheumatology
- Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome
- (2018) E. William St.Clair et al. Arthritis & Rheumatology
- Management of primary Sjögren’s syndrome: recent developments and new classification criteria
- (2018) Nicoletta Del Papa et al. Therapeutic Advances in Musculoskeletal Disease
- Interferon activation in primary Sjögren’s syndrome: recent insights and future perspective as novel treatment target
- (2018) Iris L. A. Bodewes et al. Expert Review of Clinical Immunology
- Dysregulation of NF-kB in glandular epithelial cells results in Sjögren’s-like features
- (2018) Xiaoyan Wang et al. PLoS One
- Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
- (2018) Jodi L. Karnell et al. ADVANCED DRUG DELIVERY REVIEWS
- Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome
- (2018) Saba Nayar et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphomagenesis in Sjögren's syndrome: Predictive biomarkers towards precision medicine
- (2018) Andreas V. Goules et al. AUTOIMMUNITY REVIEWS
- Comorbidities (excluding lymphoma) in Sjögren’s syndrome
- (2018) José M Pego-Reigosa et al. RHEUMATOLOGY
- B cells in Sjögren’s syndrome: from pathophysiology to therapeutic target
- (2018) Julie Mielle et al. RHEUMATOLOGY
- Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
- (2017) Eileen Samy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Syk inhibitors in clinical development for hematological malignancies
- (2017) Delong Liu et al. Journal of Hematology & Oncology
- Ectopic lymphoid neogenesis in rheumatic autoimmune diseases
- (2017) Michele Bombardieri et al. Nature Reviews Rheumatology
- Prevalence of Primary Sjögren's Syndrome in a US Population-Based Cohort
- (2017) Gabriel Maciel et al. ARTHRITIS CARE & RESEARCH
- Molecular basis of human CD22 function and therapeutic targeting
- (2017) June Ereño-Orbea et al. Nature Communications
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry
- (2017) Kimberly E. Taylor et al. Arthritis & Rheumatology
- Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
- (2017) Simon J. Bowman et al. Arthritis & Rheumatology
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
- (2016) Konstantina Delli et al. ANNALS OF THE RHEUMATIC DISEASES
- 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
- (2016) Caroline H Shiboski et al. ANNALS OF THE RHEUMATIC DISEASES
- Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium
- (2016) Pilar Brito-Zerón et al. ANNALS OF THE RHEUMATIC DISEASES
- BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation
- (2016) Jian Ding et al. CLINICAL IMMUNOLOGY
- Significance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren’s Syndrome Patients, in Salivary Duct Epithelial Cells
- (2016) Takanori Fujimura et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22
- (2016) Lamia Özgör et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation
- (2016) Michael Mingueneau et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome
- (2016) Divi Cornec et al. JOURNAL OF AUTOIMMUNITY
- Work Disability in Newly Diagnosed Patients with Primary Sjögren Syndrome
- (2016) Thomas Mandl et al. JOURNAL OF RHEUMATOLOGY
- Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study
- (2016) D J Burge et al. LUPUS
- Treatment of primary Sjögren syndrome
- (2016) Alain Saraux et al. Nature Reviews Rheumatology
- Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials
- (2016) Sumit Kunwar et al. RHEUMATOLOGY INTERNATIONAL
- High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren’s Syndrome: Data from the TEARS Randomized Trial
- (2016) Divi Cornec et al. PLoS One
- The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus
- (2015) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- IL-10-independent regulatory B-cell subsets and mechanisms of action: Table 1.
- (2015) Avijit Ray et al. INTERNATIONAL IMMUNOLOGY
- Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study
- (2015) Salvatore De Vita et al. RHEUMATOLOGY
- Development of the Sjögren’s Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy
- (2015) Divi Cornec et al. RHEUMATOLOGY
- Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study
- (2015) Raphaèle Seror et al. ARTHRITIS RESEARCH & THERAPY
- Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome
- (2015) Sandrine Jousse-Joulin et al. Arthritis & Rheumatology
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)
- (2014) P M Meiners et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
- (2014) Jacques-Eric Gottenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis
- (2014) Jadwiga Bienkowska et al. PLoS One
- Tear Cathepsin S as a Candidate Biomarker for Sjögren's Syndrome
- (2014) Sarah F. Hamm-Alvarez et al. Arthritis & Rheumatology
- Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Sjögren's Syndrome
- (2013) Clio P. Mavragani et al. Annual Review of Pathology-Mechanisms of Disease
- Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis
- (2013) E. William St.Clair et al. ARTHRITIS AND RHEUMATISM
- The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
- (2013) Fabien B. Vincent et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Different Stages of Primary Sjogren's Syndrome Involving Lymphotoxin and Type 1 IFN
- (2013) L. Shen et al. JOURNAL OF IMMUNOLOGY
- Diagnosis of pathological minor salivary glands in primary Sjogren’s syndrome by using Raman spectroscopy
- (2013) Lili Xue et al. LASERS IN MEDICAL SCIENCE
- CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome
- (2013) E. Astorri et al. RHEUMATOLOGY
- Evaluation of Histologic, Serologic, and Clinical Changes in Response to Abatacept Treatment of Primary Sjögren's Syndrome: A Pilot Study
- (2013) Sabine Adler et al. ARTHRITIS CARE & RESEARCH
- Salivary Gland Dysfunction and Xerostomia in Sjögren's Syndrome
- (2013) Siri Beier Jensen et al. Oral and Maxillofacial Surgery Clinics of North America
- Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation
- (2012) Olutayo Odusanwo et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
- (2012) Zana Brkic et al. ANNALS OF THE RHEUMATIC DISEASES
- Expansion of Autoreactive Unresponsive CD21−/lowB Cells in Sjögren's Syndrome-Associated Lymphoproliferation
- (2012) D. Saadoun et al. ARTHRITIS AND RHEUMATISM
- Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial
- (2012) Katrine Brække Norheim et al. PLoS One
- Risk of Non-Hodgkin's Lymphoma in Primary Sjögren's Syndrome: A Population-Based Study
- (2012) Svein J. Johnsen et al. ARTHRITIS CARE & RESEARCH
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- TNF-α inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation
- (2011) Yoshiko Yamamura et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
- (2011) Roy A Fava et al. ARTHRITIS RESEARCH & THERAPY
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- B-cell tolerance breakdown in Sjögren's Syndrome: Focus on BAFF
- (2010) Marie-Michèle Varin et al. AUTOIMMUNITY REVIEWS
- A Role for Lymphotoxin in Primary Sjogren's Disease
- (2010) L. Shen et al. JOURNAL OF IMMUNOLOGY
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
- (2009) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome
- (2009) J. Pijpe et al. ARTHRITIS AND RHEUMATISM
- B cell-targeted therapies in Sjögren's syndrome
- (2009) Gabriel J. Tobón et al. AUTOIMMUNITY REVIEWS
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- The weight of interleukin-6 in B cell-related autoimmune disorders
- (2009) Pierre Youinou et al. JOURNAL OF AUTOIMMUNITY
- Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren syndrome in salivary glands of non-obese diabetic mice
- (2009) Margaret K Gatumu et al. ARTHRITIS RESEARCH & THERAPY
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial
- (2007) A Hartkamp et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started